effects [qlco]
Selective Estrogen Receptor Modulator [horm, phsu]
Raloxifene [orch, phsu]
coronary [bpoc]
Raloxifene [orch, phsu]
Heart [bpoc]
Trial [resa]
subgroup [virs]
Age [orga]
Raloxifene [orch, phsu]
Heart [bpoc]
Trial [resa]
Raloxifene [orch, phsu]
Selective Estrogen Receptor Modulator [horm, phsu]
coronary [bpoc]
Events [evnt]
Women [popg]
Established [qlco]
coronary heart disease [dsyn]
Coronary heart disease risk [inpr]
Detailed [qlco]
Raloxifene [orch, phsu]
coronary [bpoc]
subgroups [virs]
Post [tmco]
Methods [inpr]
postmenopausal [tmco]
Women [popg]
N NOS [aapp, imft]
Age [orga]
randomized [resa]
Raloxifene [orch, phsu]
mg/d [qnco]
placebo [topp]
5 6 [fndg]
coronary [bpoc]
Assessed [acty]
treatment [ftcn]
Group [idcn]
Women [popg]
Coronary heart disease risk [inpr]
Established [qlco]
coronary heart disease [dsyn]
Raloxifene [orch, phsu]
coronary [bpoc]
Events [evnt]
subgroup [virs]
Post [tmco]
Age [orga]
subgroup [virs]
Age Categories [aggp]
Defined [cnce]
Initiative [menp]
randomized [resa]
Trial [resa]
Raloxifene [orch, phsu]
coronary [bpoc]
Events [evnt]
Age [orga]
Interaction [ftcn]
P NOS [aapp, imft]
coronary [bpoc]
Events [evnt]
Women [popg]
Age [orga]
Assigned [ftcn]
Raloxifene [orch, phsu]
Events [evnt]
Compared [acty]
placebo [topp]
Events [evnt]
Hazard Ratio [qnco]
P NOS [aapp, imft]
Absolute Risk Reduction [qnco]
Women [popg]
treated [topp]
treatment [ftcn]
Group [idcn]
coronary [bpoc]
Events [evnt]
Women [popg]
Age [orga]
Conclusions [idcn]
postmenopausal [tmco]
Women [popg]
Increased [qnco]
coronary [bpoc]
Events [evnt]
lack [qlco]
Benefit [qnco]
Raloxifene [orch, phsu]
subgroups [virs]
Circulation [phsf]
